paediatric oncology third edition
Paediatric Oncology, Third edition
$288.00 Original price was: $288.00.$4.99Current price is: $4.99. Add to cart
Sale!

Paediatric Oncology, Third edition

Original price was: $288.00.Current price is: $4.99.

-98%

Flash Sale: Any ebook for just 4.99 USD only

  • Pay with Any Debit/Credit Card
  • Affordable Prices for Readers
Guaranteed Safe Checkout

The Developmental Crisis: Paediatric Oncology, Third edition

Children do not get adult cancers. A child with cancer is suffering from a violent malfunction of embryological development, requiring massive doses of chemotherapy that would literally kill a full-grown adult. Paediatric Oncology, Third edition is a brutally precise, universally recognized clinical manual detailing exactly how to safely administer these lethal doses. This volume provides the absolute, non-negotiable medical blueprints required to cure the child while trying not to destroy the adult they will become.

Mastering the Acute Lymphoblastic Leukemia (ALL) Protocol

The core philosophy of this text is the multi-year assault. The manual aggressively details the standard of care for pediatric ALL. It dictates exactly how a pediatric oncologist manages a 3-year-old whose bone marrow is 90% leukemia, detailing the brutal, precise sequence of induction, consolidation, and three years of maintenance chemotherapy, achieving a staggering 90% cure rate for a disease that used to be universally fatal.

Navigating the Late Effects

The book provides a masterclass in survivorship tragedy. It dictates the exact clinical pathways for managing the cost of the cure. It rigorously explores the devastating reality that curing a child with cranial radiation and anthracyclines mathematically guarantees severe cognitive deficits, growth stunting, and a massive risk of secondary cancers and heart failure by the time they reach their 30s.

Frequently Asked Questions (FAQs)

Does this book cover adult lung or prostate cancer?
Absolutely not. It is exclusively focused on *pediatric malignancies* (leukemias, brain tumors, embryonal solid tumors) and their unique developmental biology.

Who is the primary audience?
It is the absolute, mandatory definitive reference for Pediatric Oncologists, Pediatric Hematologists, Oncology Nurses, and Pediatric Surgeons.